Prof. Dr. Mario Schiffer

Publikationen Prof. Dr. Mario Schiffer

Kannenkeril D, Bosch A, Kolwelter J, Striepe K, Berner L, Pietschner R, Ott C, Schiffer M, Achenbach S, Schmieder RE:(2026)PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease.Clin Res Cardiol. 2026;115(2): 220-231
Kollerits B, Kotsis F, Schneider MP, Schultheiss UT, Weissensteiner H, Schönherr S, Forer L, Meiselbach H, Wanner C, Eckardt KU, Dieplinger H, Kronenberg F, GCKD Investigators , Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Weigel A, Marschall S, Schefler E, Walz G, Köttgen A, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Gross A, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M, Steiner A, Sitter T, Krane V, Börner-Klein A, Bauer B, Oefner P, Gronwald W, Schmid M, Nadal J:(2025)Association of Serum Afamin Concentrations With Kidney Failure in Patients With CKD: Findings From the German CKD Cohort Study.Am J Kidney Dis. 2025;85(4): 432-441.e1
Bytyqi V, Kannenkeril D, Striepe K, Bosch A, Karg MV, Schmid A, Schiffer M, Uder M, Schmieder RE:(2025)Predicting blood pressure response to renal denervation based on a new approach.J Hypertens. 2025;43(3): 413-419
Günes-Altan M, Schmid A, Ott C, Bosch A, Pietschner R, Schiffer M, Uder M, Schmieder RE, Kannenkeril D:(2024)Blood pressure reduction after renal denervation in patients with or without chronic kidney disease.Clin Kidney J. 2024;17(1):
Bosch A, Kannenkeril D, Ott C, Striepe K, Schiffer M, Schmieder RE:(2024)Relation between waist circumference and the renal hemodynamic in healthy individuals.Nutr Metab Cardiovasc Dis. 2024;34(3): 755-762
Guenes-Altan M, Schmid A, Kannenkeril D, Linz P, Ott C, Bosch A, Schiffer M, Uder M, Schmieder RE:(2024)Skin sodium content as a predictor of blood pressure response to renal denervation.Hypertens Res. 2024;47(2): 361-371
Catanese L, Siwy J, Wendt R, Amann K, Beige J, Hendry B, Mischak H, Mullen W, Paterson I, Schiffer M, Wolf M, Rupprecht H:(2024)Differentiating primary and secondary FSGS using non-invasive urine biomarkers.Clin Kidney J. 2024;17(2):
Assfalg V, Miller G, Stocker F, Hüser N, Hartmann D, Heemann U, Tieken I, Zanen W, Vogelaar S, Rosenkranz AR, Schneeberger S, Függer R, Berlakovich G, Ysebaert DR, Jacobs-Tulleneers-Thevissen D, Mikhalski D, van Laecke S, Kuypers D, Mühlfeld AS, Viebahn R, Pratschke J, Melchior S, Hauser IA, Jänigen B, Weimer R, Richter N, Foller S, Schulte K, Kurschat C, Harth A, Moench C, Rademacher S, Nitschke M, Krämer BK, Renders L, Koliogiannis D, Pascher A, Hoyer J, Weinmann-Menke J, Schiffer M, Banas B, Hakenberg O, Schwenger V, Nadalin S, Lopau K, Piros L, Nemes B, Szakaly P, Bouts A, Bemelman FJ, Sanders JS, de Vries APJ, Christiaans MHL, Hilbrands L, van Zuilen AD, Arnol M, Stippel D, Wahba R:(2024)Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation-A Retrospective Multicenter Outcome Analysis.Transplantation. 2024;108(5): 1200-1211
Duara J, Torres M, Gurumani M, Molina David J, Njeim R, Kim JJ, Mitrofanova A, Ge M, Sloan A, Müller-Deile J, Schiffer M, Merscher S, Fornoni A:(2024)Oxysterol-binding protein-like 7 deficiency leads to ER stress-mediated apoptosis in podocytes and proteinuria.Am J Physiol Renal Physiol. 2024;327(3): F340-F350
Visconti V, Wirtz S, Schiffer M, Müller-Deile J:(2024)Distinct Changes in Gut Microbiota of Patients With Kidney Graft Rejection.Transplant Direct. 2024;10(3):
Stamellou E, Nadal J, Hendry B, Mercer A, Seikrit C, Bechtel-Walz W, Schmid M, Moeller MJ, Schiffer M, Eckardt KU, Kramann R, Floege J, GCKD study investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Marschall S, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Schmidt-Ott K, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M, Steiner A, Sitter T, Wanner C, Krane V, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2024)Long-term outcomes of patients with IgA nephropathy in the German CKD cohort.Clin Kidney J. 2024;17(8):
Stamellou E, Nadal J, Hendry B, Mercer A, Bechtel-Walz W, Schiffer M, Eckardt KU, Kramann R, Moeller MJ, Floege J, GCKD study investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Marschall S, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Schmidt-Ott K, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M, Steiner A, Sitter T, Wanner C, Krane V, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2024)Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort.Clin Kidney J. 2024;17(7):
Steinbrenner I, Kotsis F, Kosch R, Meiselbach H, Bärthlein B, Stockmann H, Lipovsek J, Zacharias HU, Altenbuchinger M, Dienemann T, Wytopil M, Bächle H, Sommerer C, Titze S, Weigel A, Weissensteiner H, Schönherr S, Forer L, Kurz NS, Menne J, Schlieper G, Schneider MP, Schaeffner E, Kielstein JT, Sitter T, Floege J, Wanner C, Kronenberg F, Köttgen A, Busch M, Krane V, Schmid M, Eckardt KU, Schultheiss UT, GCKD Investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Weigel A, Marschall S, Schefler E, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Groß A, Schaeffner E, Baid-Agrawal S, Theisen K, Schmidt-Ott K, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M, Steiner A, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2024)Interactive exploration of adverse events and multimorbidity in CKD.Nephrol Dial Transplant. 2024;39(12): 2016-2024
Pilgram L, Meurers T, Malin B, Schaeffner E, Eckardt KU, Prasser F, GCKD Investigators , Meiselbach H, P Schneider M, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Kraska D, Reis A, B Ekici A, Becker S, Alberth-Schmidt U, Marschall S, Schefler E, Weigel A, Walz G, Köttgen A, T Schultheiß U, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Gross A, Baid-Agrawal S, Theisen K, Schmidt-Ott K, Martin Z, Sommerer C, Aykac M, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2024)The Costs of Anonymization: Case Study Using Clinical Data.J Med Internet Res. 2024;26():
Kollerits B, Gruber S, Steinbrenner I, Schwaiger JP, Weissensteiner H, Schönherr S, Forer L, Kotsis F, Schultheiss UT, Meiselbach H, Wanner C, Eckardt KU, Kronenberg F, GCKD Investigators , Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Weigel A, Marschall S, Schefler E, Walz G, Köttgen A, Schultheiß UT, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Gross A, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M, Steiner A, Sitter T, Krane V, Börner-Klein A, Bauer B, Oefner P, Gronwald W, Schmid M, Nadal J:(2024)Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study.BMC Cancer. 2024;24(1):
Kraus A, Skoczynski K, Brötsch M, Burzlaff N, Leipziger J, Schiffer M, Büttner-Herold M, Buchholz B:(2024)P2Y2R and Cyst Growth in Polycystic Kidney Disease.J Am Soc Nephrol. 2024;35(10): 1351-1365
Wopperer FJ, Olinger E, Wiesener A, Broeker KAE, Knaup KX, Schaefer JT, Galiano M, Schneider K, Schiffer M, Genomics England Research Consortium , Büttner-Herold M, Reis A, Schmieder R, Pasutto F, Hilgers KF, Poglitsch M, Ziegler C, Shoemaker R, Sayer JA, Wiesener MS:(2024)Progressive Kidney Failure by Angiotensinogen Inactivation in the Germline.Hypertension. 2024;81(9): 1857-1868
Günes-Altan M, Bosch A, Striepe K, Bramlage P, Schiffer M, Schmieder RE, Kannenkeril D:(2024)Is GFR decline induced by SGLT2 inhibitor of clinical importance?Cardiovasc Diabetol. 2024;23(1):
Kopp C, Kittler L, Linz P, Kannenkeril D, Horn S, Chazot C, Schiffer M, Uder M, Nagel AM, Dahlmann A:(2024)Modification of Dialysate Na+ Concentration but not Ultrafiltration or Dialysis Treatment Time Affects Tissue Na+ Deposition in Patients on Hemodialysis.Kidney Int Rep. 2024;9(5): 1310-1320
Bosch A, Rauh M, Striepe K, Schiffer M, Schmieder RE, Kannenkeril D:(2024)Renal adaptation in pre-obesity patients with hypertension.J Hypertens. 2024;42(11): 1958-1965
Wei X, Weber S, Yin D, Allabauer I, Jobst-Schwan T, Wiesener M, Schiffer M, Dudziak D, Lehmann CHK, Woelfle J, Hoerning A:(2024)Pharmacodynamic Effect of mTOR Inhibition-based Immunosuppressive Therapy on T- and B-cell Subsets After Renal Transplantation.Transplant Direct. 2024;10(7):
Kurzhagen JT, Titze S, Büschges-Seraphin B, Schiffer M, Schneider MP, Eckardt KU, Hilgers KF:(2024)Spot urinary sodium in CKD patients: correlation with 24h-excretion and evaluation of commonly used prediction equations.BMC Nephrol. 2024;25(1):
Fueermann F, Heller K, Pavel M, Herbst L, Grützmann R, Schiffer M:(2024)Pancreas transplantation as rescue therapy in a patient with type 1 diabetes and concurrent subcutaneous insulin resistance.Am J Transplant. 2024;24(11): 2125-2128
Skoczynski K, Kraus A, Daniel C, Büttner-Herold M, Amann K, Schiffer M, Hermann K, Herrnberger-Eimer L, Tamm ER, Buchholz B:(2024)The extracellular matrix protein fibronectin promotes metanephric kidney development.Pflugers Arch. 2024;476(6): 963-974
Pape L, DeZwaan M, Nöhre M, Klewitz F, Kyaw Tha Tun E, Prüfe J, Schiffer L, Gertges R, Schieffer E, Albrecht A, Boeck HT, Kliem V, Wolff JK, Ludolph P, Talamo J, Nolting HD, Lieb M, Erim Y, Krusemark H, Gefeller O, Kaiser I, Tegtbur U, Schiffer M, KTx360°-Study Group , Anders P, Bauer-Hohmann M, Boyen J, Dehn-Hindenberg A, Frömel M, Falkenstern J, Kleemann J, Haffner D, Hartleib-Otto M, Haller H, Hellrung N, Kanzelmeyer N, Lerch C, Mazhari AL, Meißmer M, Pfeiffer R, Reber S, Schelper S, Wenzel M:(2024)A multimodal aftercare intervention improves the outcome after kidney transplantation - results of the KTx360° aftercare program using claims data.EClinicalMedicine. 2024;73():
Gwinner W, Anaokar S, Blogg M, Hermann B, Repetur CDP, Schiffer M:(2024)Long-Term Outcomes with Prolonged-Release Tacrolimus in Kidney Transplantation: A Retrospective Real-World Data Analysis.Ann Transplant. 2024;29():
Krusemark H, Schiffer M:(2024)[Comprehensive care for kidney transplantation-optimization of interdisciplinary support before and after kidney transplantation].Urologie. 2024;63(4): 333-340
Bytyqi V, Kannenkeril D, Striepe K, Bosch A, Schiffer M, Schmid A, Uder M, Schmieder RE:(2024)BLOOD PRESSURE RESPONDERS TO RENAL DENERVATION BASED ON A NEW DEFINITIONJ Hypertens. 2024;42 Suppl 1():
Bosch A, Schmid A, Kannenkeril D, Harazny J, Ott C, Striepe K, Guenes-altan M, Roth H, Schiffer M, Uder M, Schmieder R:(2024)WHY HAPPENS A PROGRESSIVE DECREASE OF BLOOD PRESSURE AFTER RENAL DENERVATIONJ Hypertens. 2024;42 Suppl 1():
Kannenkeril D, Guenes-altan M, Bosch A, Striepe K, Heller K, Schiffer M, Janka R, Amann K, Schmieder RE:(2024)INCREASE IN ARTERIAL STIFFNESS IN LIVING KIDNEY DONORS AFTER RENAL DONATIONJ Hypertens. 2024;42 Suppl 1():
Rodionova K, Ditting T, Holzmann K, Bach F, Cordasic N, Hilgers KF, Linz P, Schiffer M, Amann K, Veelken R:(2024)SIGNIFICANCE OF THE NAV 1.8. VOLTAGE-GATED, TETRODOTOXIN-RESISTANT SODIUM CHANNEL FOR THE RENAL SENSORY INNERVATION IN MICE AND RATSJ Hypertens. 2024;42 Suppl 1():
Rodionova K, Ditting T, Cordasic N, Hilgers KF, Schiffer M, Amann K, Ditting T:(2024)A NOVEL METHOD FOR THE ANALYSIS OF RENAL SYMPATHETIC NERVE ACTIVITY FROM MULTI-FIBER NERVE RECORDINGSJ Hypertens. 2024;42 Suppl 1():
Wei XY, Weber S, Yin DC, Allabauer I, Jobst-Schwan T, Wiesener M, Schiffer M, Dudziak D, Lehmann CHK, Woelfle J, Hoerning A:(2024)Pharmacodynamic effect of mTOR inhibition-based immunosuppressive therapy on T and B cell subsets after renal transplantationEur J Immunol. 2024;54 Suppl 1(): 1558-1558
Schmieder R, Kannenkeril D, Boehm M, Ewen S, Mahfoud F, Rump C, Stegbauer J, van der Giet M, Schiffer M, Veelken R, Uder M, Schmid A:(2024)Ultrasound-Based Renal Denervation Reduces Blood Pressure in Patients With Chronic Kidney Disease: Results of a Multicenter Prospective Randomized Sham-Controlled Blinded Investigator Initiated TrialJ Am Coll Cardiol. 2024;84 Suppl S(18): B159-B159
Schmieder R, Kannenkeril D, Boehm M, Mahfoud F, Rump LC, Stegbauer J, Van Der Giet M, Schiffer M, Veelken R, Uder M, Schmid A:(2024)EFFECT OF RENAL DENERVATION ON BLOOD PRESSURE IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND UNCONTROLLED HYPERTENSION: RESULTS OF A PROSPECTIVE RANDOMIZED SHAM-CONTROLLED STUDYJ Hypertens. 2024;42 Suppl 1():
Visconti V, Mueller-Deile J, Schiffer M, Wirtz S:(2024)Distinct changes in gut microbiota of patients with kidney graft rejectionNephrol Dial Transplant. 2024;39 Suppl _1():
Tati R, Mueller-Deile J, Walentinsson A, Sopel N, Lassen E, Ebefors K, Soederberg M, Daniel C, Hansen PBL, Schiffer M, Nystrom J, Buvall L:(2024)MiR-200b induces ZEB1 mediated upregulation of Matriptase and affects expression of podocinNephrol Dial Transplant. 2024;39 Suppl 1(): I805-I805
Visconti V, Mueller-Deile J, Schiffer M, Wirtz S:(2024)Distinct changes in gut microbiota of patients with kidney graft rejectionNephrol Dial Transplant. 2024;39 Suppl 1(): I178-I181
Noehre M, Klewitz F, Bauer-Hohmann M, Tegtbur U, Erim Y, Pape L, Schiffer M, de Zwaan M:(2024)Frequency and correlates of non-adherence in a large sample of patients after kidney transplantation: A KTx360° substudyPsychother Psychosom. 2024;93 Suppl 1(): 95-96
Kern J, Thiagarajan S, Uderhardt S, Sopel N, Schiffer M, Mueller-Deile J:(2024)Intranephron Cross-Talk through ExosomesJ Am Soc Nephrol. 2024;35 Suppl S(10):
Rose V, Fink D, Krueger R, Schoedel J, Schiffer M, Mueller-Deile J:(2024)Ex Vivo-Derived Human-Induced Pluripotent Stem Cell (hiPSC) Podocytes from a Patient with Genetic Focal Segmental Glomerulosclerosis with an INF2 MutationJ Am Soc Nephrol. 2024;35 Suppl S(10):
Bakhshiyeva E, Kranefuss M, Schiffer M, Willam C, Brox R, Kurzhagen JT:(2024)Lymphocyte Immune Assays for the Management of Immunosuppression of Kidney Transplant Patients in SepsisJ Am Soc Nephrol. 2024;35 Suppl S(10):
Pollinger L, Greve JN, Kaliman S, Abuhattum S, Kraeter M, Wiesener A, Pasutto F, Grosch M, Haak JR, Kolb C, Daniel C, Amann KU, Schiffer M, Manstein DJ, Wiesener MS, Jobst-Schwan T:(2024)The Novel MYH9 Variant, c.1270C>G, p.Arg424Gly, Causes Epstein-Fechtner Syndrome by the Modification of Nonmuscular Myosin IIA ContractionJ Am Soc Nephrol. 2024;35 Suppl S(10):
Schwarz H, Knaup KX, Wopperer FJ, Schiffer M, Buettner MJ, Amann KU, Wiesener MS:(2024)Characterization and Regulation of the Disease-Causing Mucin 1 Frameshift Protein in Patient-Derived Cells Affected by Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD)-MUC1J Am Soc Nephrol. 2024;35 Suppl S(10):
Hartner A, Cordasic N, Schiffer M, Veelken R, Amann KU, Daniel C, Hilgers KF:(2024)Matrix Metalloprotease Activity in Vascular Lesions of Malignant Hypertensive RatsJ Am Soc Nephrol. 2024;35 Suppl S(10):
Hutter E, Ditting T, Meissner C, Cordasic N, Linz P, Hilgers KF, Schiffer M, Amann KU, Veelken R, Rodionova K:(2024)Impaired Long-Term and Short-Term Control of Sympathetic Nerve Activity in Nonhypertensive Dahl S Salt-Sensitive RatsJ Am Soc Nephrol. 2024;35 Suppl S(10):
Kannenkeril D, Schmieder RE, Boehm M, Mahfoud F, Rump LC, Stegbauer J, van der Giet M, Schiffer M, Veelken R, Uder M, Schmid A:(2024)Renal Denervation Is Effective in Reducing Blood Pressure in Patients with CKD: Results of a Multicenter, Prospective, Randomized, Sham-Controlled, Blinded, Investigator-Initiated TrialJ Am Soc Nephrol. 2024;35 Suppl S(10):
Rodionova K, Hutter E, Ditting T, Cordasic N, Hilgers KF, Linz P, Schiffer M, Schmieder RE, Amann KU, Veelken R:(2024)Increased Blood Pressure in Mice with Impaired Function of Afferent Renal Nerves Due to Lack of Sodium Nav1.8 ChannelsJ Am Soc Nephrol. 2024;35 Suppl S(10):
Kannenkeril D, Guenes-Altan M, Bosch A, Striepe K, Schiffer M, Amann KU, Schmieder RE:(2024)Increase in Arterial Stiffness in Living Kidney Donors after Kidney DonationJ Am Soc Nephrol. 2024;35 Suppl S(10):
Rumpff C, Lieb V, Wullich B, Schiffer M, Kunath F, Apel H:(2024)Kidney transplantation in prostate cancer patients after local therapy with curative intent: a systematic review.World J Urol. 2024;42(1):
Haak JR, Kolb C, Pollinger L, Grosch M, Drummond IA, Haller H, Hildebrandt F, Schiffer M, Rinschen MM, Jobst-Schwan T:(2024)Retinol Binding Protein 4 Is a Marker for Proteinuria in Humans and ZebrafishJ Am Soc Nephrol. 2024;35 Suppl S(10):
Bolanos-Palmieri P, Krueger R, Azeloglu EU, Schiffer M:(2024)Identification of RNASE1 as a Novel Contributor to Cytoskeleton Remodeling in PodocytesJ Am Soc Nephrol. 2024;35 Suppl S(10):
Yarbakht M, Hinrichs M, Hecker M, Kocademir M, Mirzaei Z, Schiffer M, Mueller-Deile J:(2024)Effects of Nanoplastic Particles on the KidneyJ Am Soc Nephrol. 2024;35 Suppl S(10):
Pape L, Schiffer M:(2024)A Multimodal Aftercare Intervention Improves Outcome after Kidney Transplantation: Results of the KTx360° Aftercare Program Using Claims DataJ Am Soc Nephrol. 2024;35 Suppl S(10):
Guenes-Altan M, Schmid A, Kannenkeril D, Linz P, Ott C, Bosch A, Schiffer M, Uder M, Schmieder R:(2023)SKIN SODIUM CONTENT AS A PREDICTOR OF BLOOD PRESSURE RESPONSE TO RENAL DENERVATIONJ Hypertens. 2023;41 Suppl 3(): E250-E251
Guenes-Altan M, Bosch A, Striepe K, Schiffer M, Bramlage P, Schmieder RE, Kannenkeril D:(2023)IS GFR DECLINE INDUCED BY SGLT-2 INHIBITOR OF CLINICAL IMPORTANCE?Nephrol Dial Transplant. 2023;38 Suppl 1(): I87-I88
Gunes-Altan M, Schmid A, Ott C, Bosch A, Schiffer M, Uder M, Schmieder R, Kannenkeril D:(2023)BLOOD PRESSURE REDUCTION AFTER RENAL DENERVATION IN PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE: THE ERLANGER EXPERIENCEJ Hypertens. 2023;41 Suppl 3(): E256-E256
Kannenkeril D, Bosch A, Kolwelter J, Striepe K, Pietschner R, Ott C, Schiffer M, Achenbach S, Schmieder RE:(2023)PCSK-9-INHIBITOR THERAPY IMPROVES ENDOTHELIAL FUNCTION IN HIGH-RISK PATIENTS WITH CARDIOVASCULAR DISEASEJ Hypertens. 2023;41 Suppl 1(): E293-E293
Schmid A, Ott C, Bosch A, Schiffer M, Uder M, Schmieder RE, Kannenkeril D:(2023)BLOOD PRESSURE REDUCTION AFTER RENAL DENERVATION IN PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE: THE ERLANGER EXPERIENCEJ Hypertens. 2023;41 Suppl 1(): E484-E484
Rodionova K, Veelken R, Cordasic N, Hilgers KF, Schmieder RE, Schiffer M, Amann K, Ditting T:(2023)A Novel Method For The Analysis Of Renal Sympathetic Nerve Activity From Multi-fiber Nerve RecordingsHypertension. 2023;80 Suppl 1():
Rodionova K, Ditting T, Lindner S, Linz PR, Cordasic N, Hilgers KF, Schiffer M, Schmieder RE, Amann K, Veelken R:(2023)The Positive Effect Of Renal Denervation Persists Even Through Regrowth Of Afferent Axons Improving Renal Afferent Nerve Activity During High Sodium Intake In RatsHypertension. 2023;80 Suppl 1():
Rodionova K, Ditting T, Holzmann K, Bach F, Linz PR, Hilgers KF, Schmieder RE, Schiffer M, Amann K, Veelken R:(2023)Significance Of The Nav 1.8. Voltage-gated, Tetrodotoxin-resistant Sodium Channel For The Renal Sensory Innervation In Mice And RatsHypertension. 2023;80 Suppl 1():
Rodionova K, Ditting T, Hilgers KF, Linz P, Schmieder RE, Ott C, Schiffer M, Amann K, Veelken R:(2023)EMPAGLIFLOZIN IMPROVES IMPAIRED SENSITIVITY OF AFFERENT NEURONS WITH RENAL AXONSJ Hypertens. 2023;41 Suppl 3(): E75-E75
Rodionova K, Ditting T, Linz P, Hilgers KF, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R:(2023)HIGH SODIUM INTAKE - EFFECTS ON AFFERENT RENAL NERVE ACTIVITYJ Hypertens. 2023;41 Suppl 3(): E75-E75
Wopperer F, Olinger E, Knaup K, Wiesener A, Broeker K, Schiffer M, Hilgers K, Pasutto F, Sayer J, Wiesener M:(2023)RECOGNITION OF RENAL TUBULAR DYSGENESIS IN ADOLESCENT CKD BY BIALLELIC AGT VARIANTS REQUIRED BROAD GENETIC ANALYSISNephrol Dial Transplant. 2023;38 Suppl 1(): I211-I211
Guenes-Altan M, Bosch A, Striepe K, Schiffer M, Bramlage P, Schmieder RE, Kannenkeril D:(2023)Is GFR decline induced by SGLT-2 inhibitor of clinical importance?Diabetologia. 2023;66 Suppl 1(SUPPL 1): S352-S352
Rose V, Sopel N, Miedl D, Krueger R, Kraus A, Schiffer M, Muller-Deile J:(2023)PATIENT-SPECIFIC HUMAN INDUCED PLURIPOTENT STEM CELL (HIPSC)-DERIVED PODOCYTESNephrol Dial Transplant. 2023;38 Suppl 1(): I253-I253
Ekici A, Knaup K, Schneider K, Wopperer F, Wiesener A, Dieterle A, Schiffer M, Reis A, Pasutto F, Wiesener M:(2023)WHENWHOLE EXOME SEQUENCING IS NOT GOOD ENOUGH: BACK TO THE ROOTS OR FORWARD TO THE FUTURENephrol Dial Transplant. 2023;38 Suppl 1(): I224-I225
Knaup K, Schneider K, Rehrl S, Wopperer F, Schiffer M, Buettner-Herold M, Amann K, Schloetzer-Schrehardt U, Wiesener M:(2023)CHARACTERIZATION AND REGULATION OF THE PATHOGENIC MUCIN 1 FRAMESHIFT PROTEIN IN PATIENT DERIVED CELLS AFFECTED BY ADTKD-MUC1Nephrol Dial Transplant. 2023;38 Suppl 1(): I210-I210
Loderbauer L, Schneider K, Knaup K, Wopperer F, Schiffer M, Amann K, Broeker K, Buettner-Herold M, Wiesener M:(2023)EXPRESSION OF THE COLLAGEN IV α345MOLECULE ALONG THE RENAL TUBULE IN HEALTH AND DISEASENephrol Dial Transplant. 2023;38 Suppl 1(): I3-I3
Stamellou E, Nadal J, Seikrit C, Hendry B, Mercer A, Schmidt M, Moeller MJ, Schiffer M, Eckardt KU, Floege J:(2023)THE NATURAL HISTORY OF FSGS IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) COHORTNephrol Dial Transplant. 2023;38 Suppl 1(): I386-I387
Stamellou E, Nadal J, Seikrit C, Hendry B, Mercer A, Moeller MJ, Schmidt M, Schiffer M, Eckardt KU, Floege J:(2023)THE NATURAL HISTORY OF IGA NEPHROPATHY IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) COHORTNephrol Dial Transplant. 2023;38 Suppl 1(): I373-I373
Mueller DIH, Achenbach S, Kopp C, Schiffer M, Bittner D:(2023)IMMUNOADSORPTION IN NONISCHEMIC CARDIOMYOPATHY - INSIGHTS FROM A REAL-WORLD CLINICAL SCENARIOJ Am Coll Cardiol. 2023;81 Suppl A(8): 312-312
Steinbrenner I, Sekula P, Kotsis F, von Cube M, Cheng Y, Nadal J, Schmid M, Schneider MP, Krane V, Nauck M, Eckardt KU, Schultheiss UT, GCKD investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2023)Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study.Nephrol Dial Transplant. 2023;38(6): 1430-1438
Moest T, Jahn AE, Heller K, Schiffer M, Adler W, Rohde M, Weber M, Kesting MR, Lutz R:(2023)Peculiarities in the panoramic radiograph of patients with secondary hyperparathyroidism due to terminal renal disease: a radiologic controlled comparative study.Oral Radiol. 2023;39(1): 125-132
Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, Bramlage P, Nöh L, Schiffer M, Uder M, Achenbach S, Schmieder RE:(2023)The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial.Clin Res Cardiol. 2023;112(1): 134-144
Pietschner R, Bosch A, Kannenkeril D, Striepe K, Schiffer M, Achenbach S, Schmieder RE, Kolwelter J:(2023)Is vascular remodelling in patients with chronic heart failure exaggerated?ESC Heart Fail. 2023;10(1): 245-254
Bosch A, Poglitsch M, Kannenkeril D, Kolwelter J, Striepe K, Ott C, Rauh M, Schiffer M, Achenbach S, Schmieder RE:(2023)Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure.ESC Heart Fail. 2023;10(3): 1635-1642
Staef M, Ott C, Kannenkeril D, Striepe K, Schiffer M, Schmieder RE, Bosch A:(2023)Determinants of arterial stiffness in patients with type 2 diabetes mellitus: a cross sectional analysis.Sci Rep. 2023;13(1):
Hartner A, Dambietz T, Cordasic N, Willam C, Burzlaff N, Brötsch M, Daniel C, Schiffer M, Amann K, Veelken R, Schley G, Hilgers KF:(2023)No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats.Front Physiol. 2023;14():
Lale N, Ditting T, Hilgers KF, Linz P, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R, Rodionova K:(2023)Afferent neurons of the kidney with impaired firing pattern in inflammation - role of sodium currents?Pflugers Arch. 2023;475(11): 1329-1342
Pickny L, Hindermann M, Ditting T, Hilgers KF, Linz P, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R, Rodionova K:(2023)Myocardial infarction with a preserved ejection fraction-the impaired function of the cardio-renal baroreflex.Front Physiol. 2023;14():
Naas S, Krüger R, Knaup KX, Naas J, Grampp S, Schiffer M, Wiesener M, Schödel J:(2023)Hypoxia controls expression of kidney-pathogenic MUC1 variants.Life Sci Alliance. 2023;6(9):
Grampp S, Kraus A, Skoczynski K, Schiffer M, Krüger R, Naas S, Schödel J, Buchholz B:(2023)Hypoxia induces polycystin-1 expression in the renal epithelium.R Soc Open Sci. 2023;10(5):
Grampp S, Krüger R, Lauer V, Uebel S, Knaup KX, Naas J, Höffken V, Weide T, Schiffer M, Naas S, Schödel J:(2023)Hypoxia hits APOL1 in the kidney.Kidney Int. 2023;104(1): 53-60
Kraus A, Rose V, Krüger R, Sarau G, Kling L, Schiffer M, Christiansen S, Müller-Deile J:(2023)Characterizing Intraindividual Podocyte Morphology In Vitro with Different Innovative Microscopic and Spectroscopic Techniques.Cells. 2023;12(9):
Rederer A, Rose V, Krüger R, Schmittutz L, Swierzy I, Fischer L, Thievessen I, Bauer J, Friedrich O, Schiffer M, Müller-Deile J:(2023)Partner, Neighbor, Housekeeper and Dimension: 3D versus 2D Glomerular Co-Cultures Reveal Drawbacks of Currently Used Cell Culture Models.Int J Mol Sci. 2023;24(12):
Sommerer C, Müller-Krebs S, Nadal J, Schultheiss UT, Friedrich N, Nauck M, Schmid M, Nußhag C, Reiser J, Eckardt KU, Zeier M, Hayek SS, German Chronic Kidney Disease Investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Kraska D, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Marschall S, Schefler E, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Schmidt-Ott K, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2023)Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKD.Kidney Int Rep. 2023;8(11): 2265-2275
Schneider MP, Schmid M, Nadal J, Krane V, Saritas T, Busch M, Schultheiss UT, Meiselbach H, Friedrich N, Nauck M, Floege J, Kronenberg F, Wanner C, Eckardt KU, GCKD study investigators , Eckardt KU, Meiselbach H, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2023)Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study.Kidney Med. 2023;5(11):
Reimer KC, Nadal J, Meiselbach H, Schmid M, Schultheiss UT, Kotsis F, Stockmann H, Friedrich N, Nauck M, Krane V, Eckardt KU, Schneider MP, Kramann R, Floege J, Saritas T, GCKD study investigators , Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Weigel A, Marschall S, Schefler E, Walz G, Köttgen A, Kotsis F, Meder S, Mitsch E, Reinhard U, Schaeffner E, Baid-Agrawal S, Theisen K, Schmidt-Ott K, Zeier M, Sommerer C, Aykac M, Wolf G, Paul R, Börner-Klein A, Bauer B, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W:(2023)Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort.Bone Res. 2023;11(1):
Cejka V, Störk S, Nadal J, Schmid M, Sommerer C, Sitter T, Meiselbach H, Busch M, Schneider MP, Saritas T, Schultheiss UT, Kotsis F, Wanner C, Eckardt KU, Krane V, GCKD Study Investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2023)Differential Prognostic Utility of Adiposity Measures in Chronic Kidney Disease.J Ren Nutr. 2023;33(4): 546-554
Naas S, Schiffer M, Schödel J:(2023)Hypoxia and renal fibrosis.Am J Physiol Cell Physiol. 2023;325(4): C999-C1016
Schaefer JT, Schulz-Heise S, Rueckel A, Rauh M, Juengert J, Galiano M, Meier N, Woelfle J, Schiffer M, Hoerning A:(2023)Frequency and impact of enteric hyperoxaluria in pediatric short bowel syndrome: a retrospective single centre study.Front Pediatr. 2023;11():
de Fijter J, Dreyer G, Mallat M, Budde K, Pratschke J, Klempnauer J, Zeier M, Arns W, Hugo C, Rump LC, Hauser I, Schenker P, Schiffer M, Grimm MO, Kliem V, Olbricht CJ, Pisarski P, Banas B, Suwelack B, Hakenberg O, Berlakovich G, Schneeberger S, van de Wetering J, Berger S, Bemelman F, Kuypers D, Heidt S, Rahmel A, Claas F, Peeters P, Oberbauer R, Heemann U, Krämer BK, Eurotransplant Senior DR-compatible Program (ESDP) Study Group , Tieken I, Haasnoot G, van Meel M, Rump LC, Rosenkranz A, Horn S, Margreiter R, Schneeberger S, Oberbauer R, Pohanka E, Függer F, Mühlbacher F, Berlakovich G, Meurisse M, Weekers L, Ysebaert D, Wissing KM, Mikhalski D, Mourad M, van Biesen W, Kuypers D, Floege J, Anthuber M, Viebahn R, Schenker P, Budde K, Pratschke J, Zidek W, Melchior S, Woitas R, Strassburg CH, Hugo C, Wirth M, Schiffer M, Kribben A, Pisarski P, Fichtner-Feigl S, Haubitz M, Weimer R, Weithofer P, Fornara P, Fisher L, Sester U, Zeier M, Kliem V, Klempnauer L, Grimm MO, Kunzendorf U, Stippel D, Arns W, Mönch C, Nitschke M, Bartels M, Krämer B, Kruger B, Heemann U, Werner J, Hoyer J, Wolters HH, Suwelack B, Lutz J, Banas B, Hakenberg O, Olbricht CJ, Kalus M, Schwenger V, Nadalin S, Schröppel B, Lopau K, Seelen MAJ, Berger SP, de Fijter JW, van der Linden SJ, Christiaans MHL, van de Wetering J, van Zuilen AD, Bemelman F, Nurmohamed A, Hilbrands L:(2023)A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program.Kidney Int. 2023;104(3): 552-561
Bosch A, Kannenkeril D, Ott C, Guenes-Altan M, Striepe K, Schiffer M, Schmieder RE:(2023)RELATION BETWEEN WAIST CIRCUMFERENCE AND THE RENAL HEMODYNAMIC IN PATIENTS WITH UNCOMPLICATED HYPERTENSION GRADE 1-2J Hypertens. 2023;41 Suppl 3(): E264-E264
Bosch A, Schmid A, Kannenkeril D, Ott C, Harazny J, Striepe K, Guenes-Altan M, Schiffer M, Uder M, Schmieder RE:(2023)RENAL DENERVATION REDUCES RETINAL ARTERIAL REMODELING IN PATIENTS WITH TREATMENT RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUSJ Hypertens. 2023;41 Suppl 3(): E296-E297
Striepe K, Schiffer M, Schmieder R:(2022)[Renal denervation : Really an alternative to reducing blood pressure?]Internist (Berl). 2022;63(3): 330-340
Sopel N, Ohs A, Schiffer M, Müller-Deile J:(2022)A Tight Control of Non-Canonical TGF-β Pathways and MicroRNAs Downregulates Nephronectin in Podocytes.Cells. 2022;11(1):
Friedrich AC, Linz P, Nagel AM, Rosenhauer D, Horn S, Schiffer M, Uder M, Kopp C, Dahlmann A:(2022)Hemodialysis Patients with Cardiovascular Disease Reveal Increased Tissue Na+ Deposition.Kidney Blood Press Res. 2022;47(3): 185-193
Birkefeld K, Bauer-Hohmann M, Klewitz F, Kyaw Tha Tun EM, Tegtbur U, Pape L, Schiffer L, Schiffer M, de Zwaan M, Nöhre M:(2022)Prevalence of Mental Disorders in a German Kidney Transplant Population: Results of a KTx360°-Substudy.J Clin Psychol Med Settings. 2022;29(4): 963-976
Protze J, Naas S, Krüger R, Stöhr C, Kraus A, Grampp S, Wiesener M, Schiffer M, Hartmann A, Wullich B, Schödel J:(2022)The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression.J Biol Chem. 2022;298(3):
Suwelack B, Berger K, Wolters H, Gerß JWO, Bormann E, Wörmann V, Burgmer M, SoLKiD study group , Koch M, Kröncke S, Weimer R, Rainer L, Sommerer C, Zeier M, Budde K, Halleck F, Ivens K, Hansen A, Reinke P, Pascher A, Mühlfeld A, Floege J, Wahba R, Vitinius F, Kribben A, Eisenberger U, Hugo C, Quick C, Nitschke M, Derad I, Rath T, Mönch C, Schiffer M, Güler F, Krüger B, Bönnighoff R, Hauser I, Platschek S, Lopau K, Pein U, Weigand K, Feldkamp T, Kunzendorf U:(2022)Results of the prospective multicenter SoLKiD cohort study indicate bio-psycho-social outcome risks to kidney donors 12 months after donation.Kidney Int. 2022;101(3): 597-606
Scholz JK, Kraus A, Lüder D, Skoczynski K, Schiffer M, Grampp S, Schödel J, Buchholz B:(2022)Loss of Polycystin-1 causes cAMP-dependent switch from tubule to cyst formation.iScience. 2022;25(6):
Kheirkhah A, Lamina C, Kollerits B, Schachtl-Riess JF, Schultheiss UT, Forer L, Sekula P, Kotsis F, Eckardt KU, Kronenberg F, GCKD Investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2022)PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function.Clin J Am Soc Nephrol. 2022;17(6): 809-818
Wopperer FJ, Knaup KX, Stanzick KJ, Schneider K, Jobst-Schwan T, Ekici AB, Uebe S, Wenzel A, Schliep S, Schürfeld C, Seitz R, Bernhardt W, Gödel M, Wiesener A, Popp B, Stark KJ, Gröne HJ, Friedrich B, Weiß M, Basic-Jukic N, Schiffer M, Schröppel B, Huettel B, Beck BB, Genomics England Research Consortium , Sayer JA, Ziegler C, Büttner-Herold M, Amann K, Heid IM, Reis A, Pasutto F, Wiesener MS:(2022)Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases.Kidney Int. 2022;102(2): 405-420
Schneider MP, Schmid M, Nadal J, Wanner C, Krane V, Floege J, Saritas T, Busch M, Sitter T, Friedrich N, Stockmann H, Meiselbach H, Nauck M, Kronenberg F, Eckardt KU, GCKD Study Investigators , Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Paul R, Börner-Klein A, Bauer B, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W:(2022)Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort Study.Am J Kidney Dis. 2022;80(4): 483-494.e1
Rose V, Sopel N, Ohs A, Warnecke C, Schiffer M, Mueller-Deile J:(2022)GENERATION OF PATIENT-SPECIFIC HIPSC-PODOCYTES TO STUDY PHENOTYPE-SPECIFIC ALTERATIONS AND TEST THERAPEUTIC TARGETS EX VIVONephrol Dial Transplant. 2022;37 Suppl 3(): I807-I809
Ursu R, Sopel N, Ohs A, Tati R, Buvall L, Nyström J, Schiffer M, Müller-Deile J:(2022)Glomerular Endothelial Cell-Derived miR-200c Impairs Glomerular Homeostasis by Targeting Podocyte VEGF-A.Int J Mol Sci. 2022;23(23):
Popp B, Ekici AB, Knaup KX, Schneider K, Uebe S, Park J, Bafna V, Meiselbach H, Eckardt KU, Schiffer M, Reis A, Kraus C, Wiesener M:(2022)Prevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease study.Eur J Hum Genet. 2022;30(12): 1413-1422
Yin D, Fu J, Chen R, Shushakova N, Allabauer I, Wei XY, Schiffer M, Dudziak D, Rong S, Hoerning A:(2022)A Modified Surgical Technique for Kidney Transplantation in Mice.J Vis Exp. 2022;(185):
Kolwelter J, Striepe K, Bosch A, Kannenkeril D, Ott C, Schiffer M, Schmieder RE:(2022)Change of renal function after short-term use of cardioprotective agents in patients with type 2 diabetes is not accurately assessed by the change of estimated glomerular filtration rate: an observational study.Diabetol Metab Syndr. 2022;14(1):
Rodionova K, Ditting T, Hilgers KF, Peter L, Schmieder RE, Ott C, Schiffer M, Amann K, Veelken R:(2022)Empagliflozin Improves Impaired Sensitivity Of Afferent Neurons With Renal AxonsHypertension. 2022;79 Suppl 1():
Rodionova K, Ditting T, Linz P, Hilgers KF, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R:(2022)High Sodium Intake Effects On Afferent Renal Nerve ActivityHypertension. 2022;79 Suppl 1():
Kannenkeril D, Bosch A, Striepe K, Berner L, Pietschner R, Kolwelter J, Ott C, Schiffer M, Achenbach S, Schmieder RE:(2022)Evolocumab Alters Vascular Function in Patients With Cardiovascular DiseaseCirculation. 2022;146 Suppl 1():
Bosch A, Poglitsch M, Kannenkeril D, Ott C, Pietschner R, Striepe K, Schiffer M, Schmieder RE:(2022)ANGIOTENSIN PROFILES IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES WITH COMBINATION THERAPY OF EMPAGLIFLOZIN AND LINAGLIPTIN VERSUS METFORMIN AND INSULIN GLARGINEJ Hypertens. 2022;40 Suppl 1(SUPPL 1): E283-E284
Kannenkeril D, Ott C, Bosch A, Striepe K, Pietschner R, Schiffer M, Schmieder RE:(2022)IS BASAL NITRIC OXIDE ACTIVITY OF THE RENAL VASCULATURE ALTERED? ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL COMPARING TWO COMBINATION THERAPIESJ Hypertens. 2022;40 Suppl 1(SUPPL): E59-E59
Kannenkeril D, Ott C, Bosch A, Striepe K, Pietschner R, Schiffer M, Schmieder RE:(2022)IS BASAL NITRIC OXIDE ACTIVITY OF THE RENAL VASCULATURE ALTERED? ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL COMPARING TWO COMBINATION THERAPIESJ Hypertens. 2022;40 Suppl 1(SUPPL): E59-E59
Pietschner R, Kolwelter J, Bosch A, Striepe K, Kannenkeril D, Ott C, Schiffer M, Achenbach S, Schmieder RE:(2022)DETAILED ANALYSIS OF VASCULAR STIFFNESS IN PATIENTS WITH CHRONIC HEART FAILUREJ Hypertens. 2022;40 Suppl 1(SUPPL 1): E129-E129
Pietschner R, Kolwelter J, Bosch A, Striepe K, Kannenkeril D, Ott C, Schiffer M, Achenbach S, Schmieder RE:(2022)DETAILED ANALYSIS OF VASCULAR STIFFNESS IN PATIENTS WITH CHRONIC HEART FAILUREJ Hypertens. 2022;40 Suppl 1(SUPPL): E129-E129
Bihlmaier K, Grampp S, Wiliam C, Schiffer M, Herbst L:(2022)Endogenous <i>De Novo</i> Synthesis of Isopropanol Following Severe Non-Diabetic Ketoacidosis in a Patient With Duchenne Muscular DystrophyJ Endocrinol Metab. 2022;12(3): 107-110
Moest T, Lutz R, Jahn AE, Heller K, Schiffer M, Adler W, Deschner J, Weber M, Kesting MR:(2022)Frequency of the necessity of dentoalveolar surgery or conservative treatment in patients before kidney transplantation depending on the duration of dialysis and causative nephrological disease.Clin Oral Investig. 2022;26(3): 2383-2390
Schwarz H, Popp B, Airik R, Torabi N, Knaup KX, Stoeckert J, Wiech T, Amann K, Reis A, Schiffer M, Wiesener MS, Schueler M:(2022)Biallelic ANKS6 mutations cause late-onset ciliopathy with chronic kidney disease through YAP dysregulation.Hum Mol Genet. 2022;31(9): 1357-1369
Apel H, Rother U, Wach S, Schiffer M, Kunath F, Wullich B, Heller K:(2022)Transplant Ureteral Stenosis after Renal Transplantation: Risk Factor Analysis.Urol Int. 2022;106(5): 518-526
Rassner M, Baur R, Wäsch R, Schiffer M, Schneider J, Mackensen A, Engelhardt M:(2021)Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma.BMC Nephrol. 2021;22(1):
Fazzini F, Lamina C, Raftopoulou A, Koller A, Fuchsberger C, Pattaro C, Del Greco FM, Döttelmayer P, Fendt L, Fritz J, Meiselbach H, Schönherr S, Forer L, Weissensteiner H, Pramstaller PP, Eckardt KU, Hicks AA, Kronenberg F, GCKD Investigators , Eckardt KU, Meiselbach H, Schneider M, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Kraska D, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2021)Association of mitochondrial DNA copy number with metabolic syndrome and type 2 diabetes in 14 176 individuals.J Intern Med. 2021;290(1): 190-202
Schiffer L, Gertges R, Nöhre M, Schieffer E, Tegtbur U, Pape L, de Zwaan M, Schiffer M:(2021)Use and preferences regarding internet-based health care delivery in patients with chronic kidney disease.BMC Med Inform Decis Mak. 2021;21(1):
Karch A, Schindler D, Kühn-Steven A, Blaser R, Kuhn KA, Sandmann L, Sommerer C, Guba M, Heemann U, Strohäker J, Glöckner S, Mikolajczyk R, Busch DH, Schulz TF, for the Transplant Cohort of the German Center for Infection Research (DZIF Transplant Cohort) Consortium , Lehmann A, Ganser A, Lange B, Maecker-Kolhoff B, Tönshoff B, Morath C, Rieger C, Falk C, Schmaderer C, Pohle D, Sturm E, Jäckel E, Kohlmayer F, Anton G, Krause G, Wichmann HE, Mix H, Vehreschild JJ, Bucher J, Hädicke-Jarboui J, Weiss KH, Wagner K, Pape L, Frey L, Renders L, Verbeek M, Schiffer M, Zirngibl M, Kreusser MM, Neuenhahn M, Geßner M, Lang P, Nadalin S, Meuer S, Giese T, Iftner T, Illig T, Ganzenmüller T, Welte T, Bethge W:(2021)The transplant cohort of the German center for infection research (DZIF Tx-Cohort): study design and baseline characteristics.Eur J Epidemiol. 2021;36(2): 233-241
Hugo C, Weihprecht H, Banas B, Schröppel B, Jank S, Arns W, Schenker P, Rath T, Hergesell O, Feldkamp T, Hermann B, Schiffer M:(2021)Renal Function and Patient-Reported Outcomes in Stable Kidney Transplant Patients Following Conversion From Twice-Daily Immediate-Release Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month Observational Study in Routine Clinical Practice in Germany (ADAGIO).Transplant Proc. 2021;53(5): 1484-1493
Dahlmann A, Linz P, Zucker I, Haag V, Jantsch J, Dienemann T, Nagel AM, Neubert P, Rosenhauer D, Rauh M, Horn S, Müller DN, Schiffer M, Luft FC, Uder M, Kopp C:(2021)Reduction of Tissue Na+ Accumulation After Renal Transplantation.Kidney Int Rep. 2021;6(9): 2338-2347
Steinbrenner I, Schultheiss UT, Kotsis F, Schlosser P, Stockmann H, Mohney RP, Schmid M, Oefner PJ, Eckardt KU, Köttgen A, Sekula P, German Chronic Kidney Disease Investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2021)Urine Metabolite Levels, Adverse Kidney Outcomes, and Mortality in CKD Patients: A Metabolome-wide Association Study.Am J Kidney Dis. 2021;78(5): 669-677.e1
Ott C, Jung S, Korn M, Kannenkeril D, Bosch A, Kolwelter J, Striepe K, Bramlage P, Schiffer M, Schmieder RE:(2021)Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine.Cardiovasc Diabetol. 2021;20(1):
Kolwelter J, Bosch A, Jung S, Stabel L, Kannenkeril D, Ott C, Bramlage P, Schiffer M, Achenbach S, Schmieder RE:(2021)Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure.ESC Heart Fail. 2021;8(6): 5327-5337
Menendez-Castro C, Cordasic N, Fahlbusch FB, Ekici AB, Kirchner P, Daniel C, Amann K, Velkeen R, Wölfle J, Schiffer M, Hartner A, Hilgers KF:(2021)RNA sequencing reveals induction of specific renal inflammatory pathways in a rat model of malignant hypertension.J Mol Med. 2021;99(12): 1727-1740
Moest T, Lutz R, Jahn AE, Heller K, Schiffer M, Adler W, Deschner J, Weber M, Kesting MR:(2021)Oral health of patients suffering from end-stage solid organ insufficiency prior to solid organ re-transplantation: a retrospective case series study.BMC Oral Health. 2021;21(1):
Wasielewski E, Lippler S, Knaup KX, Gary R, Aigner M, Kremer A, Pfister F, Amman K, Schiffer M, Mackensen A, Wiesener MS:(2021)BKPYV-SPECIFIC T CELLS REDUCE VIRAL LOAD IN A PRIMARY TUBULAR CELL MODELTranspl Int. 2021;34 Suppl 2(): 23-24
Rodionova K, Hindermann M, Hilgers K, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R, Ditting T:(2021)AT II Receptor Blockade and Renal Denervation: Different Interventions with Comparable Renal Effects?Kidney Blood Press Res. 2021;46(3): 331-341
Rodionova K, Hilgers KF, Rafii-Tabrizi S, Doellner J, Cordasic N, Linz P, Karl AL, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R, Ditting T:(2021)Responsiveness of afferent renal nerve units in renovascular hypertension in rats.Pflugers Arch. 2021;473(10): 1617-1629
Bach C, Knaup KX, Herrmann M, Krumbiegel M, Pfister F, Büttner-Herold M, Steffen M, Zecher D, Lopau K, Schneider K, Dieterle A, Amann K, Reis A, Schiffer M, Spriewald BM, Wiesener MS:(2021)A noninvasive diagnostic approach to retrospective donor HLA typing in kidney transplant patients using urine.Transpl Int. 2021;34(7): 1226-1238
Kremer AE, Kremer AN, Willam C, Völkl S, Verhagen J, Achenbach S, van der Meijden ED, Lang V, Aigner M, Maier C, Tenbusch M, Korn K, Lutzny-Geier G, Spoerl S, Strauß R, Vetter M, Überla K, Neurath MF, Mackensen A, Schiffer M, Hackstein H:(2021)Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity.Eur J Immunol. 2021;51(10): 2478-2484
Chatzikyrkou C, Schmieder RE, Schiffer M:(2021)Update on Treatment of Hypertension After Renal Transplantation.Curr Hypertens Rep. 2021;23(5):
Schachtl-Riess JF, Kheirkhah A, Grüneis R, Di Maio S, Schoenherr S, Streiter G, Losso JL, Paulweber B, Eckardt KU, Köttgen A, Lamina C, Kronenberg F, Coassin S, GCKD Investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2021)Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease.J Am Coll Cardiol. 2021;78(5): 437-449
Müller-Deile J, Jaremenko C, Haller H, Schiffer M, Haubitz M, Christiansen S, Falk C, Schiffer L:(2021)Chemokine/Cytokine Levels Correlate with Organ Involvement in PR3-ANCA-Associated Vasculitis.J Clin Med. 2021;10(12):
Hennemann K, Bauer-Hohmann M, Klewitz F, Tegtbur U, Pape L, Schiffer L, Schiffer M, de Zwaan M, Nöhre M:(2021)Organ integration in kidney transplant patients - Results of a KTx360° substudy.J Psychosom Res. 2021;145():
Noehre M, Birkefeld K, Bauer-Hohmann M, Tun EMKT, Tegtbur U, Pape L, Schiffer L, Schiffer M, de Zwaan M:(2021)Prevalence of mental disorders in a German kidney transplant population - results of a KTx360 degrees-substudyJ Psychosom Res. 2021;145():
Noehre M, Hennemann K, Bauer-Hohmann M, Klewitz F, Tegtbur U, Pape L, Schiffer L, Schiffer M, de Zwaan M:(2021)Organ integration in kidney transplant patients - results of a KTx360 degrees substudyJ Psychosom Res. 2021;145():
Kannenkeril D, Jung S, Harazny J, Striepe K, Ott C, Dahlmann A, Kopp C, Schiffer M, Linz P, Nagel AM, Uder M, Schmieder RE:(2021)Tissue sodium content correlates with hypertrophic vascular remodeling in type 2 diabetes.J Diabetes Complications. 2021;35(12):
Pietschner R, Kolwelter J, Bosch A, Striepe K, Jung S, Kannenkeril D, Ott C, Schiffer M, Achenbach S, Schmieder RE:(2021)Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure.Cardiovasc Diabetol. 2021;20(1):
Pietschner R, Kolwelter J, Bosch A, Kannenkeril D, Ott C, Schiffer M, Achenbach S, Schmieder RE:(2021)Effect of SGLT2 inhibition on ketone bodies in patients with stable chronic heart failureDiabetologia. 2021;64 Suppl 1(SUPPL 1): 107-107
Moosmann J, Toka O, Linz P, Dahlmann A, Nagel AM, Schiffer M, Uder M, Cesnjevar R, Dittrich S, Kopp C:(2021)Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.Ther Adv Chronic Dis. 2021;12():
Müller-Deile J, Sarau G, Kotb AM, Jaremenko C, Rolle-Kampczyk UE, Daniel C, Kalkhof S, Christiansen SH, Schiffer M:(2021)Author Correction: Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis.Sci Rep. 2021;11(1):
Müller-Deile J, Sarau G, Kotb AM, Jaremenko C, Rolle-Kampczyk UE, Daniel C, Kalkhof S, Christiansen SH, Schiffer M:(2021)Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis.Sci Rep. 2021;11(1):
Kannenkeril D, Janka R, Bosch A, Jung S, Kolwelter J, Striepe K, Ott C, Martirosian P, Schiffer M, Uder M, Schmieder RE:(2021)Detection of Changes in Renal Blood Flow Using Arterial Spin Labeling MRI.Am J Nephrol. 2021;52(1): 69-75
Krause AV, Bertram A, Nöhre M, Bauer-Hohmann M, Schiffer M, de Zwaan M:(2021)Use of an electronic medication monitoring device to estimate medication adherence in kidney transplant patients.Transl Behav Med. 2021;11(3): 842-851
Kotsis F, Schultheiss UT, Wuttke M, Schlosser P, Mielke J, Becker MS, Oefner PJ, Karoly ED, Mohney RP, Eckardt KU, Sekula P, Köttgen A, GCKD Investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J:(2021)Self-Reported Medication Use and Urinary Drug Metabolites in the German Chronic Kidney Disease (GCKD) Study.J Am Soc Nephrol. 2021;32(9): 2315-2329
Kotb A, Klanke B, Kroll J, Schiffer M:(2021)INHIBITION OF SGLT-2 CANNOT RESCUE NEPHRIN EXPRESSION IN DIABETIC NEPHROPATHYNephrol Dial Transplant. 2021;36 Suppl 1():
Kannenkeril D, Bosch A, Kolwelter J, Striepe K, Ott C, Schiffer M, Schmieder RE:(2021)LOW DOSE-EPLERENONE TREATMENT DECREASES AORTIC STIFFNESS IN PATIENTS WITH METABOLIC SYNDROMEJ Hypertens. 2021;39 Suppl 1(): E338-E338
Kannenkeril D, Janka R, Bosch A, Jung S, Kolwelter J, Striepe K, Ott C, Martirosian P, Schiffer M, Uder M, Schmieder RE:(2021)DETECTION OF CHANGES IN RENAL BLOOD FLOW USING ARTERIAL SPIN LABELING MRIJ Hypertens. 2021;39 Suppl 1(): E307-E307
Müller-Deile J, Sopel N, Ohs A, Rose V, Gröner M, Wrede C, Hegermann J, Daniel C, Amann K, Zahner G, Schiffer M:(2021)Glomerular Endothelial Cell-Derived microRNA-192 Regulates Nephronectin Expression in Idiopathic Membranous Glomerulonephritis.J Am Soc Nephrol. 2021;32(11): 2777-2794
Yarbakht M, Sarau G, Kling L, Mueller-Deile J, Kotb A, Christiansen S, Schiffer M:(2021)ANALYZING THE EFFECT OF MICROPLASTIC PARTICLES ON HUMAN PODOCYTESNephrol Dial Transplant. 2021;36 Suppl 1(): 99-99
Rodionova K, Hilgers KF, Linz P, Schätzl J, Raschke G, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R, Ditting T:(2021)Neurogenic substance P-influences on action potential production in afferent neurons of the kidney?Pflugers Arch. 2021;473(4): 633-646
Bolanos-Palmieri P, Kotb A, Schenk H, Baehre H, Schroder P, Schiffer M:(2021)CHANGES IN THE KYNURENINE PATHWAY LEAD TO ALTERATIONS IN NAD BALANCE AND BIOENERGETICS PARAMETERS IN GLOMERULAR CELLS IN VITRO AND CONTRIBUTE TO PROTEINURIA IN A ZEBRAFISH MODELNephrol Dial Transplant. 2021;36 Suppl 1():
Ditting T, Rodionova K, Reeh P, Schmieder R, Schiffer M, Amann K, Ott C, Veelken R:(2021)AFFERENT PEPTIDERGIC NERVE FIBERS - IMPORTANCE FOR THE SALT METABOLISM BEYOND THE KIDNEYS?J Hypertens. 2021;39 Suppl 1(): E15-E15
Rodionova K, Ditting T, Pickny L, Ott C, Schmieder R, Schiffer M, Amann K, Veelken R:(2021)DIFFERENT FORMS OF AFFERENT NERVE INPUT IN CARDIAC AND RENAL DISEASE IN RATS?J Hypertens. 2021;39 Suppl 1(): E249-E250
Rodionova K, Ditting T, Fahrmeier F, Ott C, Schmieder R, Schiffer M, Amann K, Veelken R:(2021)AFFERENT RENAL NERVE PATHWAYS IN RATS - RESPONSIVENESS TO HIGH SALT INTAKEJ Hypertens. 2021;39 Suppl 1(): E250-E250
Mueller-Deile J, Sarau G, Kotb A, Daniel C, Kalkhof S, Christiansen S, Schiffer M:(2021)NOVEL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES REVEAL CHANGED METABOLOMIC PROFILE IN RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSISNephrol Dial Transplant. 2021;36 Suppl 1():
Mueller-Deile J, Sopel N, Ohs A, Kotb A, Marwin G, Daniel C, Amann K, Schiffer M:(2021)PODOCYTE AND GLOMERULAR ENDOTHELIAL CELL DERIVED MICRORNAS REGULATE PODOCYTE NEPHRONECTIN IN MEMBRANOUS GLOMERULONEPHRITISNephrol Dial Transplant. 2021;36 Suppl 1():
Noehre M, Birkefeld K, Klewitz F, Bauer-Hohmann M, Tun EMKT, Tegtbur U, Pape L, Schiffer L, Schiffer M, de Zwaan M:(2021)Prevalence of mental Illness in Patients after Kidney Transplantation - Results of an NTx360 degrees Sub-studyZ Psychosom Med Psychother. 2021;67(2): 201-202
Rose V, Sopel N, Ohs A, Warnecke C, Schiffer M, Mueller-Deile J:(2021)GENERATION OF NOVEL 3D CO-CULTURE SYSTEMS TO STUDY PODOCYTOPATHIES EX VIVO IN A PERSONALIZED MANNERNephrol Dial Transplant. 2021;36 Suppl 1(): 95-95
Sopel N, Ohs A, Schiffer M, Mueller-Deile J:(2021)PODOCYTE NEPHRONECTIN IS REGULATED BY TRANSFORMING GROWTH FACTOR BETA VIA THE CANONICAL AND NON-CANONICAL PATHWAYSNephrol Dial Transplant. 2021;36 Suppl 1():
Niculovic K, Blume L, Wedekind H, Groos S, Melk A, Schiffer M, Weinhold B, Munster-Kuehnel A:(2021)Podocyte-specific loss of sialylation in mice results in renal defects resembling human focal segmental glomerulosclerosisGlycobiology. 2021;31(12): 1746-1747
Rodionova K, Ditting T, Fahrmeier F, Ott C, Schmieder R, Schiffer M, Amann K, Veelken RA:(2020)High Sodium Diet - Role in Renal SympathodepressionFASEB J. 2020;34 Suppl 1():
Spriewald BM, Herrmann M, Bach C, Knaup KX, Krumbiegel M, Reis A, Schiffer M, Wiesener M:(2020)A NEW DIAGNOSTIC APPROACH TO HLA TESTING IN KIDNEY TRANSPLANT RECIPIENTS USING CULTURED URINE DERIVED TUBULAR CELLSHLA. 2020;95(4): 313-313
Herrmann M, Bach C, Knaup KX, Schiffer M, Spriewald B, Wiesener MS:(2020)A New Diagnostic Approach to HLA Testing in Kidney Transplant Patients Using Renal Epithelial CellsAm J Transplant. 2020;20 Suppl 3(): 704-705
Rodionova K, Hilgers KF, Paulus EM, Tiegs G, Ott C, Schmieder R, Schiffer M, Amann K, Veelken R, Ditting T:(2020)Neurogenic tachykinin mechanisms in experimental nephritis of rats.Pflugers Arch. 2020;472(12): 1705-1717
Wacker C, Schiffer M, Richterstetter M, Opgenoorth M, Apel H:(2020)Kidney Autotransplantation in a 78-Year-Old Man with Proximal Ureteral Urothelial Carcinoma after Living Donor Nephrectomy.Urol Int. 2020;104(11-12): 994-996
Hanke AA, Sundermeier T, Boeck HT, Schieffer E, Boyen J, Braun AC, Rolff S, Stein L, Kück M, Schiffer M, Pape L, de Zwaan M, Haufe S, Kerling A, Tegtbur U, Nöhre M:(2020)Influence of Officially Ordered Restrictions During the First Wave of COVID-19 Pandemic on Physical Activity and Quality of Life in Patients after Kidney Transplantation in a Telemedicine Based Aftercare Program-A KTx360° Sub Study.Int J Environ Res Public Health. 2020;17(23):
Rodionova K, Veelken R, Hilgers KF, Paulus EM, Linz P, Fischer MJM, Schenker M, Reeh P, Tiegs G, Ott C, Schmieder R, Schiffer M, Amann K, Ditting T:(2020)Afferent renal innervation in anti-Thy1.1 nephritis in rats.Am J Physiol Renal Physiol. 2020;319(5): F822-F832
Nunius C, Büttner-Herold M, Bertz S, Schiffer M, Buchholz B:(2020)Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.BMC Nephrol. 2020;21(1):
Wacker C, Weyand M, Schiffer M, Opgenoorth M:(2020)Pericardectomy after pericarditis constrictiva led to onset of transplant kidney function after 98 days of anuric kidney graft: a case report.BMC Nephrol. 2020;21(1):
de Boer S, Klewitz F, Bauer-Hohmann M, Schiffer L, Tegtbur U, Pape L, Schiffer M, de Zwaan M, Nöhre M:(2020)Knowledge About Immunosuppressant Medication and Its Correlates in a German Kidney Transplant Population - Results of a KTx360° Substudy.Patient Prefer Adherence. 2020;14(): 1699-1708
Nöhre M, Schieffer E, Hanke A, Pape L, Schiffer L, Schiffer M, de Zwaan M:(2020)Obesity After Kidney Transplantation-Results of a KTx360°Substudy.Front Psychiatry. 2020;11():
Bünemann M, Bauer-Hohmann M, Klewitz F, Kyaw Tha Tun EM, Tegtbur U, Pape L, Schiffer L, Schiffer M, de Zwaan M, Nöhre M:(2020)Beliefs about immunosuppressant medication and correlates in a German kidney transplant population.J Psychosom Res. 2020;132():
Bihlmaier K, Coras R, Willam C, Grampp S, Jabari S, Eichhorn P, Haller F, Kuramatsu J, Schwab S, Castellanos I, Birkholz T, Schüttler J, Altmeppen J, Schiffer M, Herbst L:(2020)Disseminated Multifocal Intracerebral Bleeding Events in Three Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation As Rescue Therapy.Crit Care Explor. 2020;2(9):
Wiesener A, Knaup KX, Büttner-Herold M, Dieterle A, Stoeckert J, Riedl B, Morath C, Wald A, Vondran F, Braun F, Schödel J, Schueler M, Schiffer M, Amann K, Reis A, Kraus C, Wiesener MS:(2020)Molecular diagnosis of kidney transplant failure based on urine.Am J Transplant. 2020;20(5): 1410-1416
Lieb M, Hepp T, Schiffer M, Opgenoorth M, Erim Y:(2020)Accuracy and concordance of measurement methods to assess non-adherence after renal transplantation - a prospective study.BMC Nephrol. 2020;21(1):
Lieb M, Schiffer M, Erim Y:(2020)Optimization of Electronically Monitored Non-Adherence in Highly Adherent Renal Transplant Recipients by Reducing the Dosing Frequency - A Prospective Single-Center Observational Study.Patient Prefer Adherence. 2020;14(): 1389-1401
Faulhaber-Walter R, Jiang L, Mizel D, Zerfas PM, Kopp JB, Schnermann JB, Chen L, Schiffer M:(2020)Podocyte Density and Albuminuria in Aging Diabetic Ins2± Mice with or Without Adenosine A1 Receptor Signaling.Int J Nephrol Renovasc Dis. 2020;13(): 19-26
Schiffer L, Hartleib-Otto M, Lerch C, Haller H, Pape L, Schiffer M:(2020)[Challenges in Long-Term Follow-Up Care of Patients After Kidney Transplantation in Specialized Transplant Centers].Gesundheitswesen. 2020;82(11): 890-893
Vivante A, Chacham OS, Shril S, Schreiber R, Mane SM, Pode-Shakked B, Soliman NA, Koneth I, Schiffer M, Anikster Y, Hildebrandt F:(2019)Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children.Pediatr Nephrol. 2019;34(9): 1607-1613
Müller-Deile J, Dannenberg J, Liu P, Lorenzen J, Nyström J, Thum T, Schiffer M:(2019)Identification of cell and disease specific microRNAs in glomerular pathologies.J Cell Mol Med. 2019;23(6): 3927-3939
Müller-Deile J, Schenk H, Schroder P, Schulze K, Bolaños-Palmieri P, Siegerist F, Endlich N, Haller H, Schiffer M:(2019)Circulating factors cause proteinuria in parabiotic zebrafish.Kidney Int. 2019;96(2): 342-349
Niculovic KM, Blume L, Wedekind H, Kats E, Albers I, Groos S, Abeln M, Schmitz J, Beuke E, Bräsen JH, Melk A, Schiffer M, Weinhold B, Münster-Kühnel AK:(2019)Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.J Am Soc Nephrol. 2019;30(6): 1021-1035
Müller-Deile J, Jobst-Schwan T, Schiffer M:(2019)Moving beyond GWAS and eQTL Analysis to Validated Hits in Chronic Kidney Disease.Cell Metab. 2019;29(1): 9-10
Kuppe C, Leuchtle K, Wagner A, Kabgani N, Saritas T, Puelles VG, Smeets B, Hakroush S, van der Vlag J, Boor P, Schiffer M, Gröne HJ, Fogo A, Floege J, Moeller MJ:(2019)Novel parietal epithelial cell subpopulations contribute to focal segmental glomerulosclerosis and glomerular tip lesions.Kidney Int. 2019;96(1): 80-93
Müller-Deile J, Schenk H, Niggemann P, Bolanos-Palmieri P, Teng B, Higgs A, Staggs L, Haller H, Schroder P, Schiffer M:(2019)Mutation of microphthalmia-associated transcription factor (mitf) in zebrafish sensitizes for glomerulopathy.Biol Open. 2019;8(3):
Tkachenko D, Franke L, Peters L, Schiffer M, Zimmermann T:(2019)Dyadic Coping of Kidney Transplant Recipients and Their Partners: Sex and Role Differences.Front Psychol. 2019;10():
Müller-Deile J, Schenk H, Schiffer M:(2019)[Minimal change disease and focal segmental glomerulosclerosis].Internist (Berl). 2019;60(5): 450-457
Klewitz F, Nöhre M, Bauer-Hohmann M, Tegtbur U, Schiffer L, Pape L, Schiffer M, de Zwaan M:(2019)Information Needs of Patients About Immunosuppressive Medication in a German Kidney Transplant Sample: Prevalence and Correlates.Front Psychiatry. 2019;10():
Paslakis G, Fischer-Jacobs J, Pape L, Schiffer M, Gertges R, Tegtbur U, Zimmermann T, Nöhre M, de Zwaan M:(2019)Assessment of Use and Preferences Regarding Internet-Based Health Care Delivery: Cross-Sectional Questionnaire Study.J Med Internet Res. 2019;21(5):
Schiffer L, Wiehler F, Bräsen JH, Gwinner W, Greite R, Kreimann K, Thorenz A, Derlin K, Teng B, Rong S, von Vietinghoff S, Haller H, Mengel M, Pape L, Lerch C, Schiffer M, Gueler F:(2019)Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft Rejection.Int J Mol Sci. 2019;20(10):
Tossidou I, Teng B, Worthmann K, Müller-Deile J, Jobst-Schwan T, Kardinal C, Schroder P, Bolanos-Palmieri P, Haller H, Willerding J, Drost DM, de Jonge L, Reubold T, Eschenburg S, Johnson RI, Schiffer M:(2019)Tyrosine Phosphorylation of CD2AP Affects Stability of the Slit Diaphragm Complex.J Am Soc Nephrol. 2019;30(7): 1220-1237
Pape L, Schneider N, Schleef T, Junius-Walker U, Haller H, Brunkhorst R, Hellrung N, Prokosch HU, Haarbrandt B, Marschollek M, Schiffer M:(2019)The nephrology eHealth-system of the metropolitan region of Hannover for digitalization of care, establishment of decision support systems and analysis of health care quality.BMC Med Inform Decis Mak. 2019;19(1):
Dienemann T, Schellenberg J, Heller K, Daniel C, Amann K, Hilgers KF, Schiffer M, Weidemann A:(2019)Association of donor hypertension and recipient renal function in living donor kidney transplantation: A single-center retrospective study.Clin Transplant. 2019;33(10):
Schenk H, Müller-Deile J, Schroder P, Bolaños-Palmieri P, Beverly-Staggs L, White R, Bräsen JH, Haller H, Schiffer M:(2019)Characterizing renal involvement in Hermansky-Pudlak Syndrome in a zebrafish model.Sci Rep. 2019;9(1):
Nöhre M, Bauer-Hohmann M, Klewitz F, Kyaw Tha Tun EM, Tegtbur U, Pape L, Schiffer L, de Zwaan M, Schiffer M:(2019)Prevalence and Correlates of Cognitive Impairment in Kidney Transplant Patients Using the DemTect-Results of a KTx360 Substudy.Front. Psychiatry. 2019;10():
Schmidt-Lauber C, Büttner-Herold M, Schiffer M, Wiesener MS:(2019)Tuberculous granulomatous interstitial nephritis in a renal allograft.Kidney Int. 2019;96(5):
Heller KM, Schiffer M, Opgenoorth M:(2019)0-BIOPSY &amp; KIDNEY TRANSPLANT FUNCTION OF DONOR KIDNEYS FROM ACCELERATED ORGAN ALLOCATION PROCEDURE (AOAP): REAL, RESCUE, CENTRE OFFER, COMPARED TO STANDARD EUROTRANSPLANT KIDNEY ALLOCATION SYSTEM (ETKAS) - SINGLE CENTRE ANALYSISTranspl Int. 2019;32 Suppl 3(): 18-18
Wacker C, Visconti V, Schiffer M, Opgenoorth M:(2019)PERICARDECTOMY AFTER PERICARDITIS CONSTRICTIVA LED TO ONSET OF TRANSPLANT KIDNEY FUNCTION AFTER 13 WEEKS OF ANURIC KIDNEY GRAFT - A CASE REPORTTranspl Int. 2019;32 Suppl 3(): 49-50
Klewitz F, Noehre M, Bauer-Hohmann M, Tegtbur U, Schiffer L, Pape L, Schiffer M, de Zwaan M:(2019)Information Needs of kidney transplant Patients regarding immunosuppressive Medication: Prevalence and CorrelatesZ Psychosom Med Psychother. 2019;66(1): 83-84
Ursu R, Schiffer M, Opgenoorth M:(2019)THROMBOCYTOPENIA, HAEMOLYTIC ANAEMIA, NEW ONSET HYPERTENSION AND PROTEINURIA IN A 29 WEEKS PREGNANT WOMAN WITH KIDNEY GRAFT AND ATYPICAL HAEMOLYTIC URAEMIC SYNDROME (aHUS) - CAN IT GET MORE COMPLICATED?Transpl Int. 2019;32 Suppl 3(): 49-49
Heller KM, Schiffer M, Opgenoorth M:(2019)ACCELERATED ORGAN ALLOCATION PROCEDURE (AOAP) FOR KIDNEY DONATION (REAL, RESCUE, CENTRE OFFER) IN THE EUROTRANSPLANT KIDNEY ALLOCATION SYSTEM (ETKAS), IS IT WORTH?-5 YEAR SINGLE CENTER EXPERIENCESTranspl Int. 2019;32 Suppl 3(): 44-45
Herrmann M, Gary R, Bosch J, Winkler J, Schiffer M, Opgenoorth M:(2019)CMV INFECTION WITH SIGHT THREATENING CMV RETINITIS REFRACTORY TO CONVENTIONAL TREATMENT: SALVAGE THERAPY WITH AUTOLOGOUS CMV-SPECIFIC T CELLS - A CASE REPORTTranspl Int. 2019;32 Suppl 3(): 48-48
Rinschen MM, Gödel M, Grahammer F, Zschiedrich S, Helmstädter M, Kretz O, Zarei M, Braun DA, Dittrich S, Pahmeyer C, Schroder P, Teetzen C, Gee H, Daouk G, Pohl M, Kuhn E, Schermer B, Küttner V, Boerries M, Busch H, Schiffer M, Bergmann C, Krüger M, Hildebrandt F, Dengjel J, Benzing T, Huber TB:(2018)A Multi-layered Quantitative In Vivo Expression Atlas of the Podocyte Unravels Kidney Disease Candidate Genes.Cell Rep. 2018;23(8): 2495-2508
Yasuda-Yamahara M, Rogg M, Frimmel J, Trachte P, Helmstaedter M, Schroder P, Schiffer M, Schell C, Huber TB:(2018)FERMT2 links cortical actin structures, plasma membrane tension and focal adhesion function to stabilize podocyte morphology.Matrix Biol. 2018;68-69(): 263-279
Anders HJ, Huber TB, Isermann B, Schiffer M:(2018)CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease.Nat Rev Nephrol. 2018;14(6): 361-377
Sever S, Schiffer M:(2018)Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.Kidney Int. 2018;93(6): 1298-1307
Müller-Deile J, Schroder P, Beverly-Staggs L, Hiss R, Fiedler J, Nyström J, Thum T, Haller H, Schiffer M:(2018)Overexpression of preeclampsia induced microRNA-26a-5p leads to proteinuria in zebrafish.Sci Rep. 2018;8(1):
Nöhre M, Erim Y, Vitinius F, Klewitz F, Schiffer M, de Zwaan M:(2018)[Adherence to Immunosuppressive Medication Following Organ Transplantation].Psychother Psychosom Med Psychol. 2018;68(5): 185-194
Peters L, Franke L, Tkachenko D, Schiffer M, Zimmermann T:(2018)[Impact of Emotion Regulation and Emotional Arousal on Quality of Life and Adherence of Couples after Kidney Transplantation].Psychother Psychosom Med Psychol. 2018;68(5): 202-211
Suwelack B, Wörmann V, Berger K, Gerß J, Wolters H, Vitinius F, Burgmer M, German SoLKiD consortium , Mühlfeld AS, Halleck F, Budde K, Reinke P, Sefrin A, Vitinius F, Wahba R, Hugo C, Opgenoorth M, Woznowski M, Hansen A, Kribben A, Witzke O, Platschek S, Hauser IA, Weimer R, Rainer L, Weigand K, Theil G, Kroencke S, Koch M, Schiffer M, Lehner F, Zeier M, Sommerer C, Rath T, Papadopoulos G, Feldkamp T, Fülbier A, Nitschke M, Schlieter J, Schamberger B, Lutz J, Nowak K, Krüger B, Kirchner M, Lopau K:(2018)Investigation of the physical and psychosocial outcomes after living kidney donation - a multicenter cohort study (SoLKiD - Safety of Living Kidney Donors).BMC Nephrol. 2018;19(1):
Jeon MK, Kaemmerer E, Schneider U, Schiffer M, Klaus C, Hennings J, Clahsen T, Ackerstaff T, Niggemann M, Schippers A, Longerich T, Sellge G, Trautwein C, Wagner N, Liedtke C, Gassler N:(2018)Notch inhibition counteracts Paneth cell death in absence of caspase-8.Virchows Arch. 2018;473(1): 71-83
Mueller-Deile J, Schenk H, Schroder P, Schroder P, Haller H, Schiffer M:(2018)WHEN YOUR PARTNER MAKES YOU SICK. A NEW MODEL TO INDUCE PROTEINURIA IN ZEBRAFISH USING PARABIOSISNephrol Dial Transplant. 2018;33(): 81-81
Chatzikyrkou C, Eichler J, Karch A, Clajus C, Scurt FG, Ramackers W, Lehner F, Menne J, Haller H, Mertens PR, Schiffer M:(2017)Short- and long-term effects of the use of RAAS blockers immediately after renal transplantation.Blood Press. 2017;26(1): 30-38
Schiffer M:(2017)Going single but not solo with podocytes: potentials, limitations, and pitfalls of single-cell analysis.Kidney Int. 2017;92(5): 1038-1041
Schenk H, Müller-Deile J, Kinast M, Schiffer M:(2017)Disease modeling in genetic kidney diseases: zebrafish.Cell Tissue Res. 2017;369(1): 127-141
Müller-Deile J, Dannenberg J, Schroder P, Lin MH, Miner JH, Chen R, Bräsen JH, Thum T, Nyström J, Staggs LB, Haller H, Fiedler J, Lorenzen JM, Schiffer M:(2017)Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases.Kidney Int. 2017;92(4): 836-849
Schenk H, Müller-Deile J, Schmitt R, Bräsen JH, Haller H, Schiffer M:(2017)Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb.J Clin Apher. 2017;32(6): 444-452
Müller-Deile J, Schiffer M:(2017)Podocytes from the diagnostic and therapeutic point of view.Pflugers Arch. 2017;469(7-8): 1007-1015
Jacobs R, Langer-Jacobus T, Duong M, Stahl K, Haller H, Schmidt RE, Schiffer M:(2017)Detection and quantification of rituximab in the human urine.J Immunol Methods. 2017;451(): 118-121
Duong M, Yu X, Teng B, Schroder P, Haller H, Eschenburg S, Schiffer M:(2017)Protein kinase C ϵ stabilizes β-catenin and regulates its subcellular localization in podocytes.J Biol Chem. 2017;292(29): 12100-12110
Vondran FWR, Wintterle S, Bräsen JH, Haller H, Klempnauer J, Richter N, Lehner F, Schiffer M:(2017)[Transplant Surgeon Meets Nephrologist: Important Nephrological Aspects Before and After Kidney or Liver Transplantation].Zentralbl Chir. 2017;142(2): 180-188
Müller-Deile J, Bräsen JH, Pollheimer M, Ratschek M, Haller H, Pape L, Schiffer M:(2017)Graft Growth and Podocyte Dedifferentiation in Donor-Recipient Size Mismatch Kidney Transplants.Transplant Direct. 2017;3(10):
Stahl K, Duong M, Schwarz A, Wagner AD, Haller H, Schiffer M, Jacobs R:(2017)Kinetics of Rituximab Excretion into Urine and Peritoneal Fluid in Two Patients with Nephrotic Syndrome.Case Rep Nephrol. 2017;2017():
Pape L, de Zwaan M, Tegtbur U, Feldhaus F, Wolff JK, Schiffer L, Lerch C, Hellrung N, Kliem V, Lonnemann G, Nolting HD, Schiffer M:(2017)The KTx360°-study: a multicenter, multisectoral, multimodal, telemedicine-based follow-up care model to improve care and reduce health-care costs after kidney transplantation in children and adults.BMC Health Serv Res. 2017;17(1):
Wu R, Wilton R, Cuff ME, Endres M, Babnigg G, Edirisinghe JN, Henry CS, Joachimiak A, Schiffer M, Pokkuluri PR:(2017)A novel signal transduction protein: Combination of solute binding and tandem PAS-like sensor domains in one polypeptide chain.Protein Sci. 2017;26(4): 857-869
Bertram A, Pabst S, Zimmermann T, Schiffer M, de Zwaan M:(2016)How can you be adherent if you don't know how?Transpl Int. 2016;29(7): 830-2
Müller-Deile J, Schiffer M:(2016)Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?Pediatr Nephrol. 2016;31(3): 393-405
Korstanje R, Deutsch K, Bolanos-Palmieri P, Hanke N, Schroder P, Staggs L, Bräsen JH, Roberts IS, Sheehan S, Savage H, Haller H, Schiffer M:(2016)Loss of Kynurenine 3-Mono-oxygenase Causes Proteinuria.J Am Soc Nephrol. 2016;27(11): 3271-3277
Teng B, Schroder P, Müller-Deile J, Schenk H, Staggs L, Tossidou I, Dikic I, Haller H, Schiffer M:(2016)CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes.Diabetes. 2016;65(12): 3667-3679
Müller-Deile J, Gellrich F, Schenk H, Schroder P, Nyström J, Lorenzen J, Haller H, Schiffer M:(2016)Overexpression of TGF-β Inducible microRNA-143 in Zebrafish Leads to Impairment of the Glomerular Filtration Barrier by Targeting Proteoglycans.Cell Physiol Biochem. 2016;40(5): 819-830
Suhling H, Gottlieb J, Bara C, Taubert R, Jäckel E, Schiffer M, Bräsen JH:(2016)[Chronic rejection: Differences and similarities in various solid organ transplants].Internist (Berl). 2016;57(1): 25-37
Schiffer L, Krautzig S, Gerbig D, Bintaro P, Haller H, Schiffer M:(2016)[Rehabilitation after kidney transplantation: Old problems and new structures].Internist (Berl). 2016;57(1): 49-53
Müller-Deile J, Teng B, Schenk H, Haller H, Reiser J, Sever S, Schiffer M:(2016)Drugs targeting dynamin can restore cytoskeleton and focal contact alterations of urinary podocytes derived from patients with nephrotic syndrome.Ann Transl Med. 2016;4(21):
Zimmermann T, Pabst S, Bertram A, Schiffer M, de Zwaan M:(2016)Differences in emotional responses in living and deceased donor kidney transplant patients.Clin Kidney J. 2016;9(3): 503-9
Hanke N, King BL, Vaske B, Haller H, Schiffer M:(2015)A Fluorescence-Based Assay for Proteinuria Screening in Larval Zebrafish (Danio rerio).Zebrafish. 2015;12(5): 372-6
Schiffer M, Teng B, Gu C, Shchedrina VA, Kasaikina M, Pham VA, Hanke N, Rong S, Gueler F, Schroder P, Tossidou I, Park JK, Staggs L, Haller H, Erschow S, Hilfiker-Kleiner D, Wei C, Chen C, Tardi N, Hakroush S, Selig MK, Vasilyev A, Merscher S, Reiser J, Sever S:(2015)Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models.Nat Med. 2015;21(6): 601-9
Pabst S, Bertram A, Zimmermann T, Schiffer M, de Zwaan M:(2015)Physician reported adherence to immunosuppressants in renal transplant patients: Prevalence, agreement, and correlates.J Psychosom Res. 2015;79(5): 364-71
Sörensen-Zender I, Bhayana S, Susnik N, Rolli V, Batkai S, Baisantry A, Bahram S, Sen P, Teng B, Lindner R, Schiffer M, Thum T, Melk A, Haller H, Schmitt R:(2015)Zinc-α2-Glycoprotein Exerts Antifibrotic Effects in Kidney and Heart.J Am Soc Nephrol. 2015;26(11): 2659-68
Müller-Deile J, Schiffer L, Hiss M, Haller H, Schiffer M:(2015)A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis.Eur J Clin Invest. 2015;45(12): 1260-9
Weismüller TJ, Lerch C, Evangelidou E, Strassburg CP, Lehner F, Schrem H, Klempnauer J, Manns MP, Haller H, Schiffer M:(2015)A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation.Transpl Int. 2015;28(5): 519-28
Lukasz A, Beneke J, Thamm K, Kielstein JT, Menne J, Mikesch JH, Schmidt BM, Haller H, Kümpers P, David S, Schiffer M:(2015)Involvement of Angiopoietin-2 and Tie2 Receptor Phosphorylation in STEC-HUS Mediated by Escherichia coli O104:H4.Mediators Inflamm. 2015;2015():
Schiffer L, Worthmann K, Haller H, Schiffer M:(2015)CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis - from bench to bedside?Clin Exp Immunol. 2015;179(1): 85-9
Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, Engelmann S, Vega-Warner V, Fang H, Halbritter J, Somers MJ, Tan W, Shril S, Fessi I, Lifton RP, Bockenhauer D, El-Desoky S, Kari JA, Zenker M, Kemper MJ, Mueller D, Fathy HM, Soliman NA, SRNS Study Group , Hildebrandt F, Repetto HA, MacTaggart P, Johnstone L, Alexander S, Hodson E, Mache C, Jungraithmayr TC, Aufricht C, Arbeiter K, Lilova M, Sweeny C, Filler G, Licht C, Chan SY, Skalova S, Seeman T, Nuutinen M, Antignac C, Briese S, Querfeld U, Franke I, Bachmann H, Kirschstein M, Weber LT, Hoppe B, Beck BB, Habbig S, Mayer B, Büscher R, Mallmann R, Vester U, Latta K, Pohl M, Häffner K, Patzer L, Henne T, Pape L, Schiffer M, Schwarz A, Kiepe D, Schäfer F, Tönshoff B, Rönnefarth G, Strehlau JS, Schumacher M, Beetz R, Klaus G, Fehrenbach H, Kuwertz-Broeking E, Konrad M, Schulze-Everding A, Hoefele J, Muscheistes J, Wigger M, Bald M, Leichter H, Reusz G, Louis D, Senguttuvan P, Aravind R, Padmaraj R, Manorajan M, Nampoothiri S, Sharma JS, Bagga A, Choudry S, Schreiber R, Frishberg Y, Cleper R, Chenin G, Gianviti A, Al-Kandari F, Tasic V, Ch GS, Keng WT, Bokenkamp A, Hashmi S, Moorani KN, Anacleto F, Wasilewska A, Drozdz D, Mizerska-Wasiak M, Szczpanska M, Tsygin AN, El Desoky SM, Albalwi M, Bogdanovic R, Burkhalter F, Rudin C, Pasch A, Neuhaus TJ, Odermatt U, Marx-Berger D, Laube G, Spartà G, Attrach I, Tanpaiboon P, Noyan A, Bakkaloglu SA, Besbas N, Gok F, Ozaltin F, Bakkaloglu A, Comak E, Gür-Güven A, Nayir A, Berdeli A, Serdaroglu E, Soylu A, Dursun I, Milford DV, Kerecuk L, Saleem MA, Trompeter RS, Sayer J, Scheinman J, Bitzer M, Gipson DS, Hanevold C, Gorman G, Pollak M, Langman C, Dixon BP, Cadnapaphornchai MA, Hidalgo G, Gbadegesin RA, Silva C, Andreoli S, Torres AD, Roberti I, Ettenger R, Kearsley N, Mansoor O, Singh A, Feygina V, Kaskel FJ, Kaplan B, Muneeruddin S, Hsieh S, Chadha V, Weiss R, Zolotnistskaya A:(2015)A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.J Am Soc Nephrol. 2015;26(6): 1279-89

Publikationen Prof. Dr. Mario Schiffer

Notfall

Notfallinformationen UKER

Patienten & Besucher

Ärzte & Zuweiser

Forschung

Lehre